Literature DB >> 627559

Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

M S Coleman, J Donofrio, J J Hutton, L Hahn, A Daoud, B Lampkin, J Dyminski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 627559

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  59 in total

1.  Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.

Authors:  B Ullman; L J Gudas; S M Clift; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 2.  Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.

Authors:  J E Seegmiller
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

3.  A study of deoxyribonucleotide metabolism and its relation to DNA synthesis. Supercomputer simulation and model-system analysis.

Authors:  F Heinmets; R H Leary
Journal:  Cell Biophys       Date:  1991-06

4.  Adenosine deaminase deficiency: unanticipated benefits from the study of a rare immunodeficiency.

Authors:  Michael R Blackburn; Linda F Thompson
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

5.  Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.

Authors:  E W Gelfand; J J Lee; H M Dosch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.

Authors:  M S Hershfield; N M Kredich; D R Ownby; H Ownby; R Buckley
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.

Authors:  D A Carson; J Kaye; S Matsumoto; J E Seegmiller; L Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

9.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

10.  Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation.

Authors:  S H Chen; H D Ochs; C R Scott; E R Giblett; A J Tingle
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.